67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 216 / Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000012865	2014/06/30	01/03/2014	Ursodeoxycholic acid for polycystic liver disease	Ursodeoxycholic acid for polycystic liver disease - UDCA for PLD	polycystic liver disease, polycystic kidney disease	UDCA 600mg/day standard treatment	Nephrology Center, Toranomon Hospital	NULL	Recruiting	Not applicable	Not applicable	Male and Female	100	Not selected	Japan
2	NCT02021110 (ClinicalTrials.gov)	December 2013	12/12/2013	Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease	An International, Multicenter, Randomized Controlled Clinical Trial Assessing the Efficacy of Ursode ...	Polycystic Liver Disease;Polycystic Kidney, Autosomal Dominant	Drug: Ursodeoxycholic Acid	Radboud University	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Completed	18 Years	80 Years	All	34	Phase 2	Netherlands;Spain
3	EUCTR2013-003207-19-NL (EUCTR)	29/11/2013	08/08/2013	Trial to investigate the effect of ursodeoxycholic acidas a treatment of symptoms in polycystic live ...	An international, multicenter, randomized controlled clinical trial assessing the efficacy of Ursode ...	Patients suffering from symptomatic polycystic liver disease (PLD) with underlying diagnosis of isol ...	Trade Name: URSOCHOL 300	Radboud University Nijmegen Medical Center	NULL	Not Recruiting			Female: yes Male: yes	34	Phase 4	Spain;Netherlands

First Previous1Next Last